series-b
Stage
1
Investors
About
Precede Biosciences develops novel therapeutics aimed at treating gastrointestinal diseases by targeting the gut immune system to enable precision medicine approaches.
Explore Precede Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.